Scarica l'app Stockscreener
131.32
0.54%
-0.71
Dopo l'orario di chiusura:
128.75
-2.57
-1.96%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BIIB Giù?
Forum
Previsione
Frazionamento azionario
Biogen Inc Borsa (BIIB) Ultime notizie
Beutel Goodman & Co Ltd. Purchases 2,323 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen (NASDAQ:BIIB) Shares Acquired Rep. Robert Bresnahan, Jr. - MarketBeat
Biogen (BIIB) Gains FDA Fast Track for Alzheimer's Therapy - GuruFocus
Organon acquires Actemra biosimilar’s US rights from Biogen - Yahoo Finance
Biogen’s tau targeting Alzheimer’s disease therapy gets FDA Fast Track status - Seeking Alpha
Biogen’s BIIB080 gains FDA fast track for Alzheimer’s By Investing.com - Investing.com Australia
Biogen’s BIIB080 gains FDA fast track for Alzheimer’s - Investing.com India
Biogen's Investigational Tau-Targeting Therapy BIIB080 Receives FDA Fast Track Designation for the Treatment of Alzheimer's Disease - The Manila Times
Biogen’s Investigational Tau-Targeting Therapy BIIB080 Receives FDA Fast Track Designation for the Treatment of Alzheimer’s Disease - Biogen
Breakthrough: Biogen's First-of-its-Kind Alzheimer's Drug Gains FDA Fast Track Status - Stock Titan
Organon Looks To Tap Tocilizumab Potential Following Biogen Acquisition - insights.citeline.com
Biogen Inc. (NASDAQ:BIIB) Shares Bought by Headlands Technologies LLC - MarketBeat
4,298 Shares in Biogen Inc. (NASDAQ:BIIB) Acquired by Allstate Corp - MarketBeat
Biogen Inc. (NASDAQ:BIIB) Stock Holdings Decreased by Wellington Management Group LLP - MarketBeat
Biogen Inc. (NASDAQ:BIIB) Shares Sold by American Century Companies Inc. - MarketBeat
Immunomodulators Market Set to Witness Significant Growth - openPR.com
Organon Expands Biosimilar Portfolio With Tofidence Acquisition - Managed Healthcare Executive
Multiple Sclerosis Pipeline 2025: Key Companies, MOA, ROA, - openPR.com
Biogen Inc. stock outperforms competitors despite losses on the day - MSN
Biogen Says Investigational Alzheimer's Drug Receives FDA Fast Track Designation - MarketScreener
FDA-Approved Biosimilars Market: A Complete List & Latest - openPR.com
Organon buys rights to Biogen’s biosimilar targeting Roche’s Actemra - Seeking Alpha
Organon acquires US rights to arthritis biosimilar TOFIDENCE - Investing.com India
Organon acquires US rights to arthritis biosimilar TOFIDENCE By Investing.com - Investing.com Australia
Organon Claims US Market Leadership with Groundbreaking Tocilizumab Biosimilar Deal - Stock Titan
EC refers lecanemab decision to Appeal Committee - The Pharma Letter
Biogen Inc. (NASDAQ:BIIB) Holdings Lowered by Saratoga Research & Investment Management - MarketBeat
Biogen (NASDAQ:BIIB) sheds US$697m, company earnings and investor returns have been trending downwards for past five years - Yahoo Finance
Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease by the European Commission - Biogen
Biogen Inc. (NASDAQ:BIIB) Shares Sold by DnB Asset Management AS - MarketBeat
Pictet Asset Management Holding SA Trims Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Thrivent Financial for Lutherans Has $2.42 Million Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
The US Approved an Alzheimer's Drug. Seven Patients Subsequently Died - Bloomberg
The US approved an Alzheimer’s drug. Seven patients subsequently died. - The Boston Globe
United Bank Sells 2,213 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Level Four Advisory Services LLC Has $1.14 Million Stake in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Norges Bank Purchases New Shares in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Mitsubishi UFJ Trust & Banking Corp Increases Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
UniSuper Management Pty Ltd Sells 42,345 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Elo Mutual Pension Insurance Co Raises Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen Inc. (NASDAQ:BIIB) Shares Purchased by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
Biogen CEO Looks for Small Deals While Alzheimer’s Drug Ramps Up - MSN
Biogen Inc. (NASDAQ:BIIB) Shares Acquired by NEOS Investment Management LLC - MarketBeat
Vanguard Group Inc. Buys 70,368 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Virtu Financial LLC Decreases Stock Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Prudential Financial Inc. Acquires 152,992 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen Inc. (NASDAQ:BIIB) Shares Sold by HighTower Advisors LLC - MarketBeat
Eli Lilly Alzheimer’s Drug Kisunla Fails to Get EU Backing - Mint
European Drug Regulator Gives Thumbs Down To Eli Lilly's Alzheimer's Drug, Analyst Says It Is Incremental Win For BiogenEli Lilly (NYSE:LLY) - Benzinga
Lilly hits same Alzheimer’s roadblock in Europe as Eisai, Biogen - BioPharma Dive
Trend Tracker for (BIIB) - Stock Traders Daily
Mizuho Securities USA LLC Raises Stake in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen Inc. (NASDAQ:BIIB) Shares Acquired by Teacher Retirement System of Texas - MarketBeat
Natixis Advisors LLC Reduces Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Hillsdale Investment Management Inc. Buys Shares of 4,610 Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen Inc. (NASDAQ:BIIB) Stock Holdings Trimmed by Northwest & Ethical Investments L.P. - MarketBeat
BIIB SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Biogen Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
0.72%
0.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):